Skip to main content
TipRanks
Go Ultimate75% OFF

Humana (HUM) Stock Price & Analysis

3 Followers

HUM Stock Chart & Stats

No data to display
Day’s Range
N/A
52-Week Range
N/A
Previous Close
N/A
Volume
N/A
Average Volume (3M)
N/A
Market Cap
CHF 45.35B
Enterprise Value
CHF 59.05B
Total Cash (Recent Filing)
CHF 25.11B
Total Debt (Recent Filing)
CHF 12.50B
Price to Earnings (P/E)
43.4
Beta
0.75
Next Earnings
Feb 10, 2027 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
0.77%

Bulls Say, Bears Say

Bulls Say

Strong Revenue Growth

Humana has expanded revenue substantially across its insurance and healthcare-services platform, demonstrating meaningful scale and continued demand. Although growth has slowed from earlier periods, the larger revenue base can support operating investments, care capabilities, and broader member reach over the next several quarters.

Medicare Advantage Quality Strength

Exceptional Medicare Advantage Stars performance strengthens Humana’s competitive position and supports future quality-related revenue economics. High ratings can improve member appeal, broker confidence, and plan competitiveness, while also validating ongoing investments in preventive care and clinical execution.

Care Delivery Expansion

Rapid CenterWell and Medicaid expansion diversifies Humana beyond traditional insurance premiums and broadens its care-delivery footprint. Greater scale in primary care and government programs may improve member coordination, create cross-platform growth opportunities, and support longer-term medical-cost management.

Bears Say

Compressed Profitability

Profitability has deteriorated materially despite continued revenue growth, indicating that scale has not yet translated into comparable earnings quality. Lower net, EBIT, and EBITDA margins reduce financial resilience and leave less capacity to absorb adverse medical costs or fund strategic initiatives internally.

Rising Medical And Drug Costs

Higher expected medical and pharmacy cost trends create sustained pressure on Medicare Advantage and Part D profitability. Humana will need pricing, benefit design, care-management, and operating improvements to offset these increases, making margin recovery dependent on successful execution rather than revenue growth alone.

Volatile Cash Generation

Cash generation has been inconsistent, with a sharp multi-year decline followed by a strong TTM rebound. This volatility makes internal funding less predictable and complicates capital allocation, particularly as Humana continues expanding insurance membership, CenterWell operations, and other growth investments.

Humana News

HUM FAQ

What is Humana’s market cap?
Humana’s market cap is CHF45.35B.
When is Humana’s upcoming earnings report date?
Humana’s next earnings report is estimated for Feb 10, 2027 (not yet confirmed), which is in 85 days.
How were Humana’s earnings last quarter?
Humana released its earnings results on Nov 06, 2026. The company reported -CHF0.587 earnings per share for the quarter, beating the consensus estimate of -CHF0.84 by CHF0.253.
Is Humana overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Humana pay dividends?
Humana does not currently pay dividends.
What is Humana’s EPS estimate?
Humana’s EPS estimate is -6.37.
How many shares outstanding does Humana have?
Humana has 120,103,250 shares outstanding.
What happened to Humana’s price movement after its last earnings report?
Humana reported an EPS of -CHF0.587 in its last earnings report, beating expectations of -CHF0.84. Following the earnings report the stock price went same ―.
Which hedge fund is a major shareholder of Humana?
Hedge funds hold Humana shares: the largest hedge-fund position in Humana is 30,225,644 shares, and hedge funds decreased their holdings by 583.1K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology